Covered recipient · General Payments record
JOHN R VALVO
Allopathic & Osteopathic Physicians Urology
General Payments · PY2018–2024
$28,167.01
- Reported across 145 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $279.49 | 13 |
| Education | $26.38 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EDAP TECHNOMED INC | $90.00 | 6 |
| BAXTER HEALTHCARE | $54.48 | 2 |
| C. R. BARD, INC. & SUBSIDIARIES | $44.92 | 1 |
| COLOPLAST CORP | $28.95 | 1 |
| Ferring Pharmaceuticals Inc. | $26.38 | 2 |
| Medtronic, Inc. | $25.18 | 1 |
| Olympus America Inc. | $21.97 | 1 |
| Teleflex LLC | $13.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Baxter Healthcare | $25.82 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120652267 | CMS |
| Baxter Healthcare | $28.66 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120652269 | CMS |
| C. R. Bard, Inc. & Subsidiaries | $44.92 | 01/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130838624 | CMS |
| COLOPLAST CORP | $28.95 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117458340 | CMS |
| Edap Technomed Inc | $11.00 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154949188 | CMS |
| Edap Technomed Inc | $11.00 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154976235 | CMS |
| Edap Technomed Inc | $11.00 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154985088 | CMS |
| Edap Technomed Inc | $19.00 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154949186 | CMS |
| Edap Technomed Inc | $19.00 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154976233 | CMS |
| Edap Technomed Inc | $19.00 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154985086 | CMS |
| Ferring Pharmaceuticals Inc. | $13.19 | 03/05/2024 | Education | Undisputed | 01/23/2026 | 1137516381 | CMS |
| Ferring Pharmaceuticals Inc. | $13.19 | 04/09/2024 | Education | Undisputed | 01/23/2026 | 1137516385 | CMS |
| Medtronic, Inc. | $25.18 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117038092 | CMS |
| Olympus America Inc. | $21.97 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108469365 | CMS |
| Teleflex LLC | $13.99 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142096675 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.